Literature DB >> 871204

Inhibition of adrenal medullary catecholamine secretion by enflurane: I. Investigations in vivo.

M Gothert, J Wendt.   

Abstract

The effects of enflurane anesthesia on adrenal medullary catecholamine secretion and on the pressor effect of splanchnic-nerve stimulation were studied in cats given pentobarbital for basal anesthesia. Inhalation of enflurane, 1.2 and 2.2 per cent, caused dose-related inhibition of both spontaneous catecholamine release and secretion evoked by splanchnic-nerve stimulation. During inhalation of 2.2 per cent enflurane spontaneous release of epinephrine was decreased to 19 and 25 per cent, respectively, of the initial values, and the stimulated release was decreased to 30 and 15 per cent, respectively. Enflurane also inhibited the pressor effect of splanchnic-nerve stimulation, whereas that of norepinephrine was not changed significantly. These results are similar to those previously obtained with halothane and methoxyflurane. It is concluded that the decrease in catecholamine secretion caused by enflurane is in part due to a direct effect on the chromaffin cell, namely to an inhibition of the secretion-stimulating effect of acetylcholine released from splanchnic nerves.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871204

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  4 in total

1.  The action of volatile anaesthetics on stimulus-secretion coupling in bovine adrenal chromaffin cells.

Authors:  G Pocock; C D Richards
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

Review 2.  Anaesthetic management of phaeochromocytoma.

Authors:  V Pratilas; M G Pratila
Journal:  Can Anaesth Soc J       Date:  1979-07

3.  Subanesthetic sevoflurane does not affect sympathetic or parasympathetic function.

Authors:  Kazuya Kuramochi
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

Review 4.  Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Authors:  H Bönisch; K B Fink; B Malinowska; G J Molderings; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-15       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.